@a_a_free A.AA.A posts on X about $rvmd, in the, strong, $cogt the most. They currently have [---] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.
Social category influence stocks 53.33% finance 10.48% countries 4.76% cryptocurrencies 1.9% social networks 0.95% technology brands 0.95% financial services 0.95% travel destinations 0.95%
Social topic influence $rvmd 11.43%, in the 7.62%, strong 7.62%, $cogt 6.67%, $apge 5.71%, $gpcr #24, $abvx 4.76%, $prax 4.76%, $stok 4.76%, stocks 4.76%
Top accounts mentioned or mentioned by @joserestonva @hothomaswphelps @bananaoncology @avidresearch @bionavgator @seedy19tron @biohazard3737 @sharkbiotech @dedwng @pcmbio @grok @tarrikzaid @amaymd @sanctuarybio @jermdemo @biogerontology @usfda @jfais20 @wassimlaroussi3 @adamfeuerstein
Top assets mentioned Revolution Medicines, Inc. (RVMD) Cogent Biosciences, Inc. Common Stock (COGT) Apogee Therapeutics, Inc. (APGE) Structure Therapeutics Inc. (GPCR) Abivax SA (ABVX) Praxis Precision Medicines, Inc. (PRAX) Protagonist Therapeutics, Inc (PTGX) Terns Pharmaceuticals, Inc. (TERN) Avidity Biosciences, Inc. (RNA) Merck & Co., Inc. (MRK) Viridian Therapeutics, Inc. Common Stock (VRDN) Insmed, Inc. (INSM) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Oruka Therapeutics, Inc. Common Stock (ORKA) Metsera, Inc. (MTSR) Maze Therapeutics, Inc. (MAZE) Ocular Therapeutix, Inc. (OCUL) Evommune, Inc. (EVMN) Pharvaris, B.V. (PHVS) Arrowhead Research Corporation (ARWR) Apellis Pharmaceuticals, Inc. Common Stock (APLS) Cere Network (CERE) Janux Therapeutics, Inc. (JANX) Pfizer, Inc. (PFE) IDEAYA Biosciences, Inc. Common Stock (IDYA) Eli Lilly and Company (LLY) Marblex (MBX) Novo-Nordisk (NVO) Climb Bio, Inc (CLYM) Cullinan Management, Inc. (CGEM) Merus N.V. Common Shares (MRUS) Cidara Therapeutics, Inc. (CDTX) Lexeo Therapeutics, Inc (LXEO) Xenon Pharmaceuticals Inc (XENE) MapLight Therapeutics, Inc (MPLT) LB Pharmaceuticals Inc. (LBRX) Karuna Therapeutics, Inc. Common Stock (KRTX) Rubrik, Inc. (RBRK) Netskope, Inc. (NTSK) Verve Therapeutics Inc. (VERV) Monte Rosa Therapeutics, Inc. (GLUE) Regeneron Pharmaceuticals Inc (REGN) Invivyd, Inc. (IVVD) Crinetics Pharmaceuticals, Inc. (CRNX) Sionna Therapeutics, Inc. (SION) Dyne Therapeutics, Inc. (DYN) PepGen Inc. (PEPG) uniQure N.V. (QURE) Intellia Therapeutics, Inc (NTLA)
Top posts by engagements in the last [--] hours
"was not sure which one to pick either $CGEM or $CLYM but I ended up choosing $CLYM but I believe both will do well in [----] Preliminary #biopick2026 starting lineup in the link below if you see any mistakes let me know. The information was copied from your entries so should be good. Ill update for stars by Monday and release official version. Enjoy and good luck 🤞 https://t.co/jVU4pyjj52 Preliminary #biopick2026 starting lineup in the link below if you see any mistakes let me know. The information was copied from your entries so should be good. Ill update for stars by Monday and release"
X Link 2026-01-03T20:39Z [---] followers, [----] engagements
"I believe that $ARWR become a strong candidate to be Long from here. I don't like the burn cash rate but it looks the pipeline became more mature commercial soon upon approval"
X Link 2025-09-02T16:58Z [---] followers, [----] engagements
"12 days ago. $MRUS went [--] left ( $CDTX $ABVX $VRDN) may be by JP26 $CDTX $MRUS $ABVX $VRDN good candidates for M&A. $CDTX $MRUS $ABVX $VRDN good candidates for M&A"
X Link 2025-09-29T08:18Z [---] followers, [----] engagements
"$PTGX HALTED"
X Link 2025-10-10T15:24Z [---] followers, [----] engagements
"Reported EMPAVELI U.S. net product revenue of $27 million reflecting strong early launch in C3G and primary IC-MPGN and continued high patient compliance in PNH. This is clearly a blockbuster drug for $APLS"
X Link 2025-10-30T11:10Z [---] followers, [----] engagements
"My top positions going into [----] (I have plan to reduce 6-8 positions by [--] Jan): Big size: RVMDPRAX TERN COGT APGE ORKA SYRE ARWR OCUL ABVX Mid Size: STOK VRDN NAMS IONS IDYA FULC CTMX PTGX MAZE Small Size: IMVT IKTBBOT SLNO GLUE DERM"
X Link 2026-01-04T19:41Z [---] followers, 18.5K engagements
"was expecting $LXEO and $XENE data this week. but it looks that we will get the update next week"
X Link 2026-01-05T13:53Z [---] followers, [---] engagements
"Updates that I am looking for in Q1: - $LXEO(L) data update and P3 trail update - $CRNX(L) already done - $XENE(NP) data update - $MAZE(L) data update in March - $APGE (L) data update in AD and asma - $ORKA(L) HV update in IL17 - $STOK(L) AA update - $SYRE (L): Update from JNJ about their combo data - $RVMD(L): 2L P3 data - $IDYA(L): P3 data - $IKT(L): $GOSS(NP) data update https://twitter.com/i/web/status/2008182508811075757 https://twitter.com/i/web/status/2008182508811075757"
X Link 2026-01-05T14:23Z [---] followers, [----] engagements
"$APGE(L) a master class company that it's managed very well. Very good update and hope they will continue like this"
X Link 2026-01-06T11:44Z [---] followers, [----] engagements
"$PRAX Any reason for the offering They used ATM and raised 567M three months ago. Really strange for a company with 900M cash already"
X Link 2026-01-06T23:39Z [---] followers, [----] engagements
"My prediction that next will be from : $PRAX $TERN $COGT $APGE $ABVX $VRDN $STOK My top positions going into [----] (I have plan to reduce 6-8 positions by [--] Jan): Big size: RVMDPRAX TERN COGT APGE ORKA SYRE ARWR OCUL ABVX Mid Size: STOK VRDN NAMS IONS IDYA FULC CTMX PTGX MAZE Small Size: IMVT IKTBBOT SLNO GLUE DERM My top positions going into [----] (I have plan to reduce 6-8 positions by [--] Jan): Big size: RVMDPRAX TERN COGT APGE ORKA SYRE ARWR OCUL ABVX Mid Size: STOK VRDN NAMS IONS IDYA FULC CTMX PTGX MAZE Small Size: IMVT IKTBBOT SLNO GLUE DERM"
X Link 2026-01-07T20:41Z [---] followers, [----] engagements
"$MPLT and $LBRX might be the next $KRTX and $CERE. Two stocks to keep an eye on them"
X Link 2026-01-09T00:25Z [---] followers, [----] engagements
"$INSM might be cash flow positive either in Q2 or Q3 based on this print and it looks their launch is strong more than $MDGL"
X Link 2026-01-09T12:29Z [---] followers, [----] engagements
"@dedwng @PCM_bio @grok Agree $TERN OR $GPCR can be good fit but i believe there is many others"
X Link 2026-01-12T11:42Z [---] followers, [---] engagements
"$ORKA(L) I believe there is a big chance that this will outperform $APGE and $SYRE which I like them also. $ORKA gave a good update that i was expecting to achieve a half-life of 75-80 days supporting potential for twice-per-year dosing in psoriasis and quarterly dosing in HS and EVERLAST-B trial starts for ORKA-001 in December rather than H1 [----]. The only thing that I was expecting but it didn't happen. It was that they will announce the enrollment in EVERLAST-A but it didn't happen. https://twitter.com/i/web/status/2010780023746080910 https://twitter.com/i/web/status/2010780023746080910"
X Link 2026-01-12T18:24Z [---] followers, [----] engagements
"$RVMD hope we will not see the same playbook of $RNA. Hope no offering will come"
X Link 2026-01-16T17:24Z [---] followers, [----] engagements
"@Biohazard3737 @sharkbiotech @tarrikzaid $RBRK and $NTSK are my favorite in this trend"
X Link 2026-01-16T18:54Z [---] followers, [---] engagements
"When the B/O will be leaked for $GPCR. It reminds me a lot of $CERE"
X Link 2026-01-20T16:42Z [---] followers, [---] engagements
"@JoseRestonVA @HOThomasWPhelps while Apollos shared their data if you compare this clinical trail https://clinicaltrials.gov/study/NCT06436183#study-plan https://clinicaltrials.gov/study/NCT06436183#study-plan"
X Link 2026-01-21T11:55Z [---] followers, [---] engagements
"@A_May_MD I believe we might see a turnaround with $JANX they still have chance"
X Link 2026-01-22T12:14Z [---] followers, [----] engagements
"$GPCR is close to their B/O and clearly the price got leaked. Nothing else can explain the move. It reminds also of $MTSR stock behavior when reached 46$ for no reason which then discovered it was related to B/O"
X Link 2026-01-22T17:04Z [---] followers, [----] engagements
"I am super long $RVMD but saying $MRK will deploy the 30B otherwise it s very stupid take. Simple question did MRK deployed the money dedicated to SGEN in any other place. It s No. MRK BD are not stupid and they know what they are doing"
X Link 2026-01-26T20:15Z [---] followers, [----] engagements
"They also have $VERV $MAZE and $GLUE. probably next time i will follow alphabet in their biotech holdings 🤣🤣🤣 $RVMD 👀👀👀 https://t.co/hMPBOHKZ7i $RVMD 👀👀👀 https://t.co/hMPBOHKZ7i"
X Link 2026-01-27T22:10Z [---] followers, [----] engagements
"Ohtuvayre achieved 178M in Q4 [----]. Will be blockbuster in [----]. $MRK always amazing in their M&A. Hope they will be back to $RVMD soon. $MRK Announces Fourth-Quarter and Full-Year [----] Financial Results; Highlights Progress Advancing Broad Diverse Pipeline https://t.co/xeXmPq77Hp $MRK Announces Fourth-Quarter and Full-Year [----] Financial Results; Highlights Progress Advancing Broad Diverse Pipeline https://t.co/xeXmPq77Hp"
X Link 2026-02-03T11:36Z [---] followers, [----] engagements
"Hey $REGN you can learn from $MRK how to do the right M&A instead of coming up with data about not supportive M&A. $MRK $PFE interesting price action. I prefer $MRK. $MRK $PFE interesting price action. I prefer $MRK"
X Link 2026-02-03T15:20Z [---] followers, [----] engagements
"Looooool If he is a holder if your stock You don't need to do that 🤣🤣🤣🤣🤣. $IVVD found another job. @Biohazard3737 Amen @Biohazard3737 Amen"
X Link 2026-02-03T17:12Z [---] followers, [---] engagements
"Stocks that I am keeping an eye on them if they will add more to them: $CRNX $MAZE and probably will start a position in $SION"
X Link 2026-02-06T00:40Z [---] followers, [----] engagements
"@avidresearch Idya Goss nktr ocul or avbp will be one from these companies"
X Link 2026-02-09T11:35Z [---] followers, [----] engagements
"Really amused by Thomas Massie efforts. Hope all politicians like him"
X Link 2026-02-10T09:24Z [---] followers, [---] engagements
"@Sanctuary_Bio @jermdemo @biogerontology Agree with you most of the engineers that I know investing in biotech They are doing good performance better than in Tech. They have a very good analytic approach and zero sentiment towards stocks"
X Link 2026-02-10T20:33Z [---] followers, [--] engagements
"Finally my top [--] position got a B/O $RNA. How $DYN and $PEPG and $ARWR will trade Monday This B/O is very good for the sector"
X Link 2025-10-26T18:11Z [---] followers, [----] engagements
"I was lucky to get in $NKTR on Monday PR-market after I saw Adam's tweet on Sunday. I was sure that either will be $OCUL and $NKTR (you can check his newsletter to know why I was biased towards these two). Since I am already long $OCUL so I started $NKTR and the rest is UP BY 50%. Thanks Adam F"
X Link 2026-02-10T21:32Z [---] followers, [----] engagements
"Very Strong Launch by $APLS and $INSM in just two months"
X Link 2025-10-30T11:08Z [---] followers, [----] engagements
"woooow $QURE. This is really bad"
X Link 2025-11-03T12:15Z [---] followers, [----] engagements
"Something to keep an eye on it $EVMN. It will be valued at 400M not bad EV will be around 170M. $EVMN Evommune IPO priced at $16/share https://t.co/wV6RHF9eWb $EVMN Evommune IPO priced at $16/share https://t.co/wV6RHF9eWb"
X Link 2025-11-06T14:21Z [---] followers, [---] engagements
"@US_FDA Lool all of them are for big pharma"
X Link 2025-11-06T19:03Z [---] followers, [----] engagements
"This is the first time that I wish for a company to shutdown. They are basically using ATM every time to raise a good amount money and that's why they are still exist. For me They are stealing money from small investors .etc. $NTLA fuck you deeeply"
X Link 2025-11-06T21:32Z [---] followers, [----] engagements
"I feel very happy to own such quality name in my port $RVMD. A pill is raising hope for one of the deadliest cancers. The question is how fast patients should get it. $RVMD https://t.co/qNnfq59DDa A pill is raising hope for one of the deadliest cancers. The question is how fast patients should get it. $RVMD https://t.co/qNnfq59DDa"
X Link 2025-11-07T14:04Z [---] followers, [----] engagements
"to be more clear it's my top position after I sold RNA. I rotated 20% from RNA to RVMD"
X Link 2025-11-07T14:13Z [---] followers, [---] engagements
"What confidence in their pipeline Many players will be in obesity by [----] I believe that they should diversify their pipeline more. For me it's a story a la Moderna. They need to extend outside of obesity and keep doing a great job for obesity. May be time to get ASND will be better than share buyback"
X Link 2025-11-08T12:30Z [---] followers, [---] engagements
"$PHVS (L) phase [--] HAE on-demand Completed enrollment in March [----]. I believe that we will see data likely in the second half of Nov not in December"
X Link 2025-11-09T00:10Z [---] followers, [---] engagements
"I really didn't find any reason whi $IMMX valuation is depressed. Anyone has anything to share what I am missing here Thanks a lot"
X Link 2025-11-09T14:16Z [---] followers, [----] engagements
"Very good data from $COGT"
X Link 2025-11-10T12:04Z [---] followers, [----] engagements
"First One hit $COGT Let's see what will happen with $IMNM Two Onc stocks can do very well in Q4 2025: $COGT and $IMNM. Both have P3 data that can move the stock well. Two Onc stocks can do very well in Q4 2025: $COGT and $IMNM. Both have P3 data that can move the stock well"
X Link 2025-11-10T13:49Z [---] followers, [----] engagements
"@jfais20 Thanks a lot @jfais20. Appreciate it many wins to come"
X Link 2025-11-10T14:41Z [---] followers, [---] engagements
"Very good one expecting an offer from $COGT. I know that they raised cash in July but their management always want to have more cash in their hand. Offering is coming either today or Tomorrow. Hope no discount at all. $COGT (OUTPERFORM$53.00 PT): Bezuclastinib Likely to Become the Standard-of-Care for 2L GIST Following Phase [--] Data that Exceeded Expectations; Moving PT to $53/Share LIFESCI $COGT (OUTPERFORM$53.00 PT): Bezuclastinib Likely to Become the Standard-of-Care for 2L GIST Following Phase [--] Data that Exceeded Expectations; Moving PT to $53/Share LIFESCI"
X Link 2025-11-10T19:51Z [---] followers, [----] engagements
"$BHVN Vlad Coric our Chief Executive Officer and certain of our directors and their affiliated funds have indicated an interest in purchasing approximately $60M from the 150M. That's a strong endorsement for $BHVN. Great to see the management believe in what they have"
X Link 2025-11-12T11:25Z [---] followers, [----] engagements
"I still believe the data will come in Nov or max first week of December. $PHVS (L) Pharvaris Reports Third Quarter [----] Financial Results and Provides Business Update $PHVS https://t.co/kcJa4ny8pO Pharvaris Reports Third Quarter [----] Financial Results and Provides Business Update $PHVS https://t.co/kcJa4ny8pO"
X Link 2025-11-12T11:55Z [---] followers, [----] engagements
"Something that my friend @JoseRestonVA convinced me to go in for zeal. He really could see where BD will look into. $ZEAL is up 20% in the last two days. Let s see what gonna happen here. $ZEAL ceo will not comment if anyone has come with an offer at the company. Wouw. It would be easy to just say no But ZEAL also has [--] different obesity molecules either in P3 or entering P3 next year. I you buy ZEAL you get 50% of Petrelintide and 50% of CT-388 MCAP $ZEAL ceo will not comment if anyone has come with an offer at the company. Wouw. It would be easy to just say no But ZEAL also has [--] different"
X Link 2025-11-13T08:22Z [---] followers, [----] engagements
"$PHVS and $JANX which data will come first Anyone of them will be next week"
X Link 2025-11-14T20:08Z [---] followers, [----] engagements
"Strange price action on $STOK in the last 3-4 months It reminds me a lot of $MTSR. Might be something in the background ongoing. This stock will not be cheap anymore in 2027"
X Link 2025-11-18T18:51Z [---] followers, [----] engagements
"$PTGX down today due to $TAK data"
X Link 2025-12-18T20:06Z [---] followers, [---] engagements
"@WassimLaroussi3 @adamfeuerstein @sharkbiotech $RVMD and $MAZE"
X Link 2025-12-19T14:42Z [---] followers, [---] engagements
"Any reason for owning $NUVB I am leaning towards that the stock became a short not long at these level(I don't do shorts at all). $SNDX and $KURA probably deserve better valuation than them. But hope I am missing something in the story"
X Link 2025-12-22T14:52Z [---] followers, [----] engagements
"$MDGL at 13B MC. My prediction that $MDGL will stay independent company missed it when it was at 7B to acquire it but now I believe no one will pay over 15B for single product but I like the story to be standalone. My prediction that $MDGL will make M&A to acquire 1-2B company either private or public in [----] if their sales will go in the same direction as [----]. https://twitter.com/i/web/status/2003128457220214959 https://twitter.com/i/web/status/2003128457220214959"
X Link 2025-12-22T15:40Z [---] followers, [----] engagements
"Added to $TERN and $ORKA today"
X Link 2026-01-02T22:31Z [---] followers, [----] engagements
"@JoseRestonVA Yeah I got back to $STOK last week. We might hear about AA soon if somehow FDA is ok i believe that the stock will fly no need to wait for [----] but if otherwise will keep adding in weakness because this will be 5B company in [----] if all is good"
X Link 2026-01-04T21:02Z [---] followers, [---] engagements
"@Bionavgator I believe it will surprise many i believe that it will go to at least [---] by year end. I liked YE companies ORKA SYRE APGE and RAPT a lot and i believe all of them will do very well startting from 2026"
X Link 2026-01-04T21:26Z [---] followers, [---] engagements
"$ZBIO's drug is not competitive at all against AMGN. Good luck to them"
X Link 2026-01-05T12:25Z [---] followers, [----] engagements
"$APGE https://investors.apogeetherapeutics.com/news-releases/news-release-details/apogee-therapeutics-host-conference-call-report-interim-0 https://investors.apogeetherapeutics.com/news-releases/news-release-details/apogee-therapeutics-host-conference-call-report-interim-0"
X Link 2026-01-05T21:17Z [---] followers, [---] engagements
"$drug data beat $LBPH by margin. Congrats long"
X Link 2026-01-06T12:25Z [---] followers, [----] engagements
"$IMVT IMVT-1402 in Adult Participants With Active Difficult to Treat Rheumatoid Arthritis already completed recruiting in December [----] which makes me believe that we will see interim data at week12 by March [----] if IMVT wants to share that otherwise we will see full top line result at W24 by July [----] so I believe It's wise to start increase my position from now. https://twitter.com/i/web/status/2008671781809238508 https://twitter.com/i/web/status/2008671781809238508"
X Link 2026-01-06T22:47Z [---] followers, [----] engagements
"So Lee back and got his first B/O a legend is a legend. I am long APGE COGT and IDYA. Need to check $KOD as bakers added recently also. UBS pharma/biotech research update. Top Picks: $APGE $COGT $KOD $IDYA $IVA $SABS and - $VTYX. 🤓Pharma Top Picks are $LLY and $MRK. https://t.co/9CtMhNN53G UBS pharma/biotech research update. Top Picks: $APGE $COGT $KOD $IDYA $IVA $SABS and - $VTYX. 🤓Pharma Top Picks are $LLY and $MRK. https://t.co/9CtMhNN53G"
X Link 2026-01-07T11:35Z [---] followers, [---] engagements
"$STOK Reminds me a lot of $MTSR before the B/O in terms of share price. There is something in the back for $STOK"
X Link 2026-01-07T14:40Z [---] followers, [---] engagements
"Two went and two still here. Who is next $RVMD or $RNA or $VRDN or $ABVX Who is next $RVMD or $RNA or $VRDN or $ABVX"
X Link 2026-01-07T20:42Z [---] followers, [---] engagements
"@BioWino Looooool we speak about brinsupri who give a shit about arikayce"
X Link 2026-01-09T12:38Z [---] followers, [---] engagements
"As expected $MDGL will be a standalone company and happy for them $MDGL announces exclusive global license agreement with $PFE for Ervogastat a clinical-stage oral DGAT-2 inhibitor. $PFE to receive $50M upfront $MDGL announces exclusive global license agreement with $PFE for Ervogastat a clinical-stage oral DGAT-2 inhibitor. $PFE to receive $50M upfront"
X Link 2026-01-09T13:04Z [---] followers, [----] engagements
"Strange price action for $SLNO. Almost down every day"
X Link 2026-01-09T16:32Z [---] followers, [----] engagements
"@avidresearch I sized it up very well and make it top1 after $RNA B/O and INSM valuation because clearly will be taken out or will be valued as INSM"
X Link 2026-01-11T16:56Z [---] followers, [---] engagements
"@doepke_michel Only PTGX is lagging. It's way down compared to the other two. I am long $PTGX but I believe that their value got dropped a little bit after $TAK and $ALMS"
X Link 2026-01-12T09:31Z [---] followers, [---] engagements
"@Banana_Oncology I believe $COGT can be one of comings M&A and May by $PRAX"
X Link 2026-01-12T09:56Z [---] followers, [----] engagements
"Frankly speaking I liked $MBX update. Their pipeline became obesity. No position so far but it was one of my mistake in [----]. I was long the stock with an average price of [--] but got influenced by someone to sell my position for a tiny loss. Sometime it s better to stick with your DD. $MBX to Provide [----] Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference https://t.co/YL0IPkQUSC $MBX to Provide [----] Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference https://t.co/YL0IPkQUSC"
X Link 2026-01-12T20:03Z [---] followers, [---] engagements
"yeah my pick for $ORKA vs $APGE in terms of sizing/performance it's because I feel that ORKA is more de-risked than $APGE and bigger chances to show strong data against their original molecule. $APGE wild card is the combo of IL13+OX40 If that one can show strong data I do see $APGE like $RVMD or $INSM in valuation side. But it's still risky readout as it go both ways. https://twitter.com/i/web/status/2010833159592845611 https://twitter.com/i/web/status/2010833159592845611"
X Link 2026-01-12T21:55Z [---] followers, [---] engagements
"$RVMD $GPCR $PTGX $COGT $TERN and $PRAX will be difficult to see these companies as standalone by end of [----]. Probably either all or [--] of them at least will be taken"
X Link 2026-01-13T15:27Z [---] followers, [----] engagements
"$GPCR (NP) B/O coming Might be $BMY"
X Link 2026-01-13T18:03Z [---] followers, [----] engagements
"which obesity stocks left to buy for $NVO: $GPCR may some private companies May be $MBX with their new updates about their monthly programs $SEPN not sure about this one. $NVO CEO Mike Doustdar was our guest on this week's live taping of the Readout LOUD. And yes he spoke fairly plainly about his ambition to acquire another developer of obesity drugs. $5B - $20B doesn't matter it's more about expanding on their leadership in the area he told $NVO CEO Mike Doustdar was our guest on this week's live taping of the Readout LOUD. And yes he spoke fairly plainly about his ambition to acquire"
X Link 2026-01-14T19:02Z [---] followers, [----] engagements
"@jq1234t $BIIB nothing better than $SRRK or $STOK for you"
X Link 2026-01-14T20:18Z [---] followers, [---] engagements
"Can I get the three of them done plz $RVMD $ABVX and $OCUL My top positions going into [----] (I have plan to reduce 6-8 positions by [--] Jan): Big size: RVMDPRAX TERN COGT APGE ORKA SYRE ARWR OCUL ABVX Mid Size: STOK VRDN NAMS IONS IDYA FULC CTMX PTGX MAZE Small Size: IMVT IKTBBOT SLNO GLUE DERM My top positions going into [----] (I have plan to reduce 6-8 positions by [--] Jan): Big size: RVMDPRAX TERN COGT APGE ORKA SYRE ARWR OCUL ABVX Mid Size: STOK VRDN NAMS IONS IDYA FULC CTMX PTGX MAZE Small Size: IMVT IKTBBOT SLNO GLUE DERM"
X Link 2026-01-15T10:21Z [---] followers, [----] engagements
"@Andre_AGTC Where did you get the BO speculation on $PRAX"
X Link 2026-01-15T18:23Z [---] followers, [----] engagements
"$RVMD it looks like the deal will take much time as we saw probably with the $SGEN situation. It looks like the deal was leaked in its early days to negotiate a better transaction value"
X Link 2026-01-19T19:49Z [---] followers, [----] engagements
"@Banana_Oncology Believe me La lettre is credible journal in France and I am sure that their articles about $OCUL and $ABVX are correct. Might be some infos are wrong in the articles but its integrity is totally legitimate and days will tell the truth"
X Link 2026-01-20T08:56Z [---] followers, [----] engagements
"@JoseRestonVA Did you hear anything that you dont like in their JP presentation $IDYA"
X Link 2026-01-20T19:39Z [---] followers, [---] engagements
"@JoseRestonVA @HOThomasWPhelps My concern with $EVMN is that their P2 data should be out already per their clinical trail https://www.clinicaltrials.gov/study/NCT06723405cond=EVO301&rank=1&a=4&b=5 https://www.clinicaltrials.gov/study/NCT06723405cond=EVO301&rank=1&a=4&b=5"
X Link 2026-01-21T11:52Z [---] followers, [---] engagements
"@JoseRestonVA @HOThomasWPhelps Yeah agree with you but EVO301 can have value if they show something really good"
X Link 2026-01-21T19:04Z [---] followers, [---] engagements
"@JoseRestonVA @HOThomasWPhelps The good staff about $EVMN is not discussed much in X which is for me good"
X Link 2026-01-21T19:07Z [---] followers, [---] engagements
"$RVMD will not be down much because clearly the 30B helped to open the eyes of people about how much value RVMD has and it will have in the future"
X Link 2026-01-25T23:09Z [---] followers, [----] engagements
"@Archimedes20311 Lool wrong take. Working in pharma doesn't mean that you have a better take. By the way JNJ highlighted DUET readouts as key events for 2026; https://www.investor.jnj.com/pipeline/2026-Key-events/default.aspx https://www.investor.jnj.com/pipeline/2026-Key-events/default.aspx"
X Link 2026-01-27T13:19Z [---] followers, [--] engagements
"$JNJ highlighted DUET readouts as key events for [----] This will have a heavy readout on $SYRE. While I believe that TL1A + IL23 is the best combo that will show strong data . Something to watch for Q1 2026: https://www.investor.jnj.com/pipeline/2026-Key-events/default.aspx https://www.investor.jnj.com/pipeline/2026-Key-events/default.aspx"
X Link 2026-01-27T18:55Z [---] followers, [----] engagements
"@JoseRestonVA it looks they want weak dollar per Trump policy. If it's the case this will play very bad for them"
X Link 2026-01-27T21:18Z [---] followers, [---] engagements
"@MitchMartan98 @JoseRestonVA the issue that might be this time is very different due to the geo-political issues that we saw with Trump. It's messy strategy"
X Link 2026-01-27T21:32Z [---] followers, [--] engagements
"@unemon1 @seedy19tron VRDN will open 90-95% cmon man. They already have 25% of their market cap as cash + FDA data approval"
X Link 2026-01-27T23:18Z [---] followers, [--] engagements
"@BalaBioResearch you took advantage from the dip. Do they have an important catalyst this year"
X Link 2026-01-28T22:06Z [---] followers, [---] engagements
"Venezuela Iran and Gazaall of them upon reflection express America's predicament despite its arrogance and haughtiness. Trump ignorant of the nature of civilization can continue sending his soldiers and rampaging left and right but by the logic of long-term history all of this confers neither credibility nor strength upon a country. It is a phase heralding the pre-collapse of the empire even if the opposite appears to be the case. https://twitter.com/i/web/status/2017273852863074407 https://twitter.com/i/web/status/2017273852863074407"
X Link 2026-01-30T16:29Z [---] followers, [---] engagements
"@Banana_Oncology You became long OCUL"
X Link 2026-01-30T16:29Z [---] followers, [---] engagements
"The church on the Mount of Olives in Jerusalem has installed a camera and opened its doors to document the daily attacks it is subjected to by Israeli settlers passing by who spit on it out of their religious racism and extremism. These are the people that Hakeem Jeffries Ted Cruz Lindsey Graham and other Christian Zionists defend. They know very well what Christians in Palestine are subjected to but none of that means anything to them. At the same time Netanyahu speaks of defending these Israeli settlers who attack Christians and minorities. . . https://t.co/Uphd3RlI1C "
X Link 2026-01-30T16:36Z [---] followers, [---] engagements
"@Banana_Oncology @LawDawg050 I read it: i did my DD and now have a long position 😏"
X Link 2026-01-30T17:08Z [---] followers, [---] engagements
"@JoseRestonVA Today after OX40 news I believe its wise to own EVMN"
X Link 2026-01-30T19:12Z [---] followers, [---] engagements
"Congrats Team we are on it"
X Link 2026-01-30T20:25Z [---] followers, [---] engagements
"Imagine what's pure evil to encourage to divide a country into small pieces. It's not for sake to help Iranian people It's just about that terror country in EMEA. Then someone stupid/arrogant come to cheer for these fights. Hope one day we will see a real peace when all of us what ever your religion is we enjoy this life in respected way. https://twitter.com/i/web/status/2017338979109007845 https://twitter.com/i/web/status/2017338979109007845"
X Link 2026-01-30T20:47Z [---] followers, [---] engagements
"Loool see how much money will go to Isreal first then egypt and Jordan. This is charity I voted against the rule to bring this omnibus forward for a vote. Here is a breakdown of some of the most ridiculous items included in the omnibus and some America First items that were not. I offered amendments to correct these errorsall of which were blocked or refused🧵: I voted against the rule to bring this omnibus forward for a vote. Here is a breakdown of some of the most ridiculous items included in the omnibus and some America First items that were not. I offered amendments to correct these"
X Link 2026-02-03T20:13Z [---] followers, [---] engagements
"This is why Patent cliff is important for Pharma. $NVS Q4 [----] earnings: Patent Cliff Strikes: Sales Stall [----] Profit Decline Guided The long-awaited patent cliff has arrived. After a strong start to FY25 Novartis hit a wall in Q4: Net Sales declined 1% (cc) as US generic erosion for Entresto crushed the top line. While $NVS Q4 [----] earnings: Patent Cliff Strikes: Sales Stall [----] Profit Decline Guided The long-awaited patent cliff has arrived. After a strong start to FY25 Novartis hit a wall in Q4: Net Sales declined 1% (cc) as US generic erosion for Entresto crushed the top line. While"
X Link 2026-02-04T10:05Z [---] followers, [----] engagements
"Really Check who did more wars in middle east and you will find the cancer that you are supporting. All this to have a war on behalf of Isreal. Hope Iranian people will change the regime by their hands not with any one else. The Iranian regime is the greatest driver of chaos death and destruction in the Middle East. Iran's people deserve freedom from the Ayatollah's repression. The Iranian regime is the greatest driver of chaos death and destruction in the Middle East. Iran's people deserve freedom from the Ayatollah's repression"
X Link 2026-02-04T19:39Z [---] followers, [---] engagements
"This is the first time ever I saw the truth as it's. A must watch to educate yourself about what you are supporting. How does the US-funded Israeli government treat Christians in the Holy Land We asked some. Listen carefully to their accounts. This will shock you. (00:00) Monologue (05:28) How Are Christians Doing in the Holy Land (16:57) Do Christians in the Holy Land Receive Support From https://t.co/3i1LP3BRcs How does the US-funded Israeli government treat Christians in the Holy Land We asked some. Listen carefully to their accounts. This will shock you. (00:00) Monologue (05:28) How Are"
X Link 2026-02-05T08:53Z [---] followers, [----] engagements
"How this is legal $HIMS launches copy of Wegovy pill at $49. $NVO $LLY https://t.co/ikWNaPk8ku $HIMS launches copy of Wegovy pill at $49. $NVO $LLY https://t.co/ikWNaPk8ku"
X Link 2026-02-05T13:38Z [---] followers, [---] engagements
"@BigChodu I feel that it's still expensive but honestly I will choose VOR over DNTH :p while I didn't like VOR but they got good asset from china something like what rapt did :p"
X Link 2026-02-06T00:56Z [---] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing